Bryan Wahl, General Counsel at Tarsus Pharmaceuticals, Inc. (TARS), sold 2,347 shares at $16.50 ($39K) on 2022-11-30, disclosed to the SEC on 2022-12-01.
Open-market sale of $39k TARS by General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.50 | 1,183 | $20K | 50.0% |
| 2 | $16.75 | 1,164 | $19K | 50.0% |
| Total | $16.62 avg | 2,347 | $39K | 100% |
| Filing → |
| TARS | SELL | 2024-03-19 | $271K | — | Filing → |
| TARS | SELL | 2023-12-01 | $273K | — | Filing → |
| TARS | SELL | 2023-03-23 | $14K | — | Filing → |